Cargando…
Serum PCSK6 and corin levels are not associated with cardiovascular outcomes in patients undergoing coronary angiography
INTRODUCTION: Proprotein convertase subtilisin/kexin-6 (PCSK6) is a secretory protein that activates corin in the heart. Higher circulating levels of corin are associated with improved cardiovascular outcomes in patients with acute myocardial infarction. This study aimed to determine the role of ser...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6905542/ https://www.ncbi.nlm.nih.gov/pubmed/31825978 http://dx.doi.org/10.1371/journal.pone.0226129 |
_version_ | 1783478181750112256 |
---|---|
author | Yang, Shang-Feng Chou, Ruey-Hsing Lin, Shing-Jong Li, Szu-Yuan Huang, Po-Hsun |
author_facet | Yang, Shang-Feng Chou, Ruey-Hsing Lin, Shing-Jong Li, Szu-Yuan Huang, Po-Hsun |
author_sort | Yang, Shang-Feng |
collection | PubMed |
description | INTRODUCTION: Proprotein convertase subtilisin/kexin-6 (PCSK6) is a secretory protein that activates corin in the heart. Higher circulating levels of corin are associated with improved cardiovascular outcomes in patients with acute myocardial infarction. This study aimed to determine the role of serum PCSK6 and corin levels in predicting cardiovascular outcomes in patients with suspected coronary artery disease (CAD). MATERIALS AND METHODS: In total, 565 patients who had undergone coronary angiography were enrolled. Serum PCSK6 and corin levels were determined before the administration of contrast media. In this study, coronary revascularization, acute myocardial infarction, acute stroke, and death were defined as cardiovascular outcomes. All patients were followed up for at least one year after coronary angiography or until the occurrence of death. RESULTS: During a median follow-up of 691 days, 67 patients (15.7%) developed composite cardiovascular outcomes after coronary angiography, including 51 incidents of coronary revascularization, 7 instances of acute myocardial infarction, 2 acute strokes, and 15 deaths. After adjustment for demographic characteristics and all significant variables in the univariate analysis, serum levels of neither PCSK6 nor corin were associated with increased risk for cardiovascular outcomes. This correlation remained insignificant in patients with underlying hypertension, diabetes mellitus, CAD, heart failure, or chronic kidney disease (CKD). However, in patients without CKD, higher serum PCSK6 levels were associated with increased risk for cardiovascular outcomes (hazard ratio 1.380; 95% confidence interval 1.023–1.862). CONCLUSIONS: We found no association between cardiovascular outcomes and pre-procedural serum levels of PCSK6 or corin in patients undergoing coronary angiography. However, an increased risk was seen in non-CKD patients with higher PCSK6 levels. Further studies are needed to verify these results. |
format | Online Article Text |
id | pubmed-6905542 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-69055422019-12-27 Serum PCSK6 and corin levels are not associated with cardiovascular outcomes in patients undergoing coronary angiography Yang, Shang-Feng Chou, Ruey-Hsing Lin, Shing-Jong Li, Szu-Yuan Huang, Po-Hsun PLoS One Research Article INTRODUCTION: Proprotein convertase subtilisin/kexin-6 (PCSK6) is a secretory protein that activates corin in the heart. Higher circulating levels of corin are associated with improved cardiovascular outcomes in patients with acute myocardial infarction. This study aimed to determine the role of serum PCSK6 and corin levels in predicting cardiovascular outcomes in patients with suspected coronary artery disease (CAD). MATERIALS AND METHODS: In total, 565 patients who had undergone coronary angiography were enrolled. Serum PCSK6 and corin levels were determined before the administration of contrast media. In this study, coronary revascularization, acute myocardial infarction, acute stroke, and death were defined as cardiovascular outcomes. All patients were followed up for at least one year after coronary angiography or until the occurrence of death. RESULTS: During a median follow-up of 691 days, 67 patients (15.7%) developed composite cardiovascular outcomes after coronary angiography, including 51 incidents of coronary revascularization, 7 instances of acute myocardial infarction, 2 acute strokes, and 15 deaths. After adjustment for demographic characteristics and all significant variables in the univariate analysis, serum levels of neither PCSK6 nor corin were associated with increased risk for cardiovascular outcomes. This correlation remained insignificant in patients with underlying hypertension, diabetes mellitus, CAD, heart failure, or chronic kidney disease (CKD). However, in patients without CKD, higher serum PCSK6 levels were associated with increased risk for cardiovascular outcomes (hazard ratio 1.380; 95% confidence interval 1.023–1.862). CONCLUSIONS: We found no association between cardiovascular outcomes and pre-procedural serum levels of PCSK6 or corin in patients undergoing coronary angiography. However, an increased risk was seen in non-CKD patients with higher PCSK6 levels. Further studies are needed to verify these results. Public Library of Science 2019-12-11 /pmc/articles/PMC6905542/ /pubmed/31825978 http://dx.doi.org/10.1371/journal.pone.0226129 Text en © 2019 Yang et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Article Yang, Shang-Feng Chou, Ruey-Hsing Lin, Shing-Jong Li, Szu-Yuan Huang, Po-Hsun Serum PCSK6 and corin levels are not associated with cardiovascular outcomes in patients undergoing coronary angiography |
title | Serum PCSK6 and corin levels are not associated with cardiovascular outcomes in patients undergoing coronary angiography |
title_full | Serum PCSK6 and corin levels are not associated with cardiovascular outcomes in patients undergoing coronary angiography |
title_fullStr | Serum PCSK6 and corin levels are not associated with cardiovascular outcomes in patients undergoing coronary angiography |
title_full_unstemmed | Serum PCSK6 and corin levels are not associated with cardiovascular outcomes in patients undergoing coronary angiography |
title_short | Serum PCSK6 and corin levels are not associated with cardiovascular outcomes in patients undergoing coronary angiography |
title_sort | serum pcsk6 and corin levels are not associated with cardiovascular outcomes in patients undergoing coronary angiography |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6905542/ https://www.ncbi.nlm.nih.gov/pubmed/31825978 http://dx.doi.org/10.1371/journal.pone.0226129 |
work_keys_str_mv | AT yangshangfeng serumpcsk6andcorinlevelsarenotassociatedwithcardiovascularoutcomesinpatientsundergoingcoronaryangiography AT chourueyhsing serumpcsk6andcorinlevelsarenotassociatedwithcardiovascularoutcomesinpatientsundergoingcoronaryangiography AT linshingjong serumpcsk6andcorinlevelsarenotassociatedwithcardiovascularoutcomesinpatientsundergoingcoronaryangiography AT liszuyuan serumpcsk6andcorinlevelsarenotassociatedwithcardiovascularoutcomesinpatientsundergoingcoronaryangiography AT huangpohsun serumpcsk6andcorinlevelsarenotassociatedwithcardiovascularoutcomesinpatientsundergoingcoronaryangiography |